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Abstract – Hepatitis E virus (HEV) is responsible for enterically-transmitted acute hepatitis in humans with
two distinct epidemiological patterns. In endemic regions, large waterborne epidemics with thousands of
people affected have been observed, and, in contrast, in non-endemic regions, sporadic cases have been
described. Although contaminated water has been well documented as the source of infection in endemic
regions, the modes of transmission in non-endemic regions are much less known. HEV is a single-strand,
positive-sense RNA virus which is classiﬁed in the Hepeviridae family with at least four known main
genotypes (1–4) of mammalian HEV and one avian HEV. HEV is unique among the known hepatitis
viruses, in which it has an animal reservoir. In contrast to humans, swine and other mammalian animal
species infected by HEV generally remain asymptomatic, whereas chickens infected by avian HEV may
develop a disease known as Hepatitis-Splenomegaly syndrome. HEV genotypes 1 and 2 are found
exclusively in humans while genotypes 3 and 4 are found both in humans and other mammals. Several lines
of evidence indicate that, in some cases involving HEV genotypes 3 and 4, animal to human transmissions
occur. Furthermore, individuals with direct contact with animals are at higher risk of HEV infection. Cross-
species infections with HEV genotypes 3 and 4 have been demonstrated experimentally. However, not all
sources of human infections have been identiﬁed thus far and in many cases, the origin of HEV infection in
humans remains unknown.
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1. INTRODUCTION
Hepatitis E virus (HEV), the causative agent
of acute human hepatitis E, is responsible for
an important public health disease in many
developing countries of Asia and Africa [109].
ThemortalityrateassociatedwithHEVinfection
(1to4%)ishigherthanthatofhepatitisA(0.1to
2%)[107],andcanreachupto20%duringpreg-
nancy [109].HEVinfection indevelopingcoun-
tries is mostly a waterborne disease associated
with large epidemics due to contamination of
water and water supplies, and poor sanitation
conditions [6, 109]. In contrast, in industrialized
countries, including many European countries,
USAandJapan,acute hepatitisEoccurs sporad-
ically and the contamination pathways are still
not fully understood [109]. Several lines of evi-
dence, such as the absence of travel to endemic
countries or different HEV strains involved in
casesreportedfrom industrializedcountriesthan
from developing countries [22], support an
autochthonous origin of these sporadic cases.
The particularity of HEV is that, among all
known major hepatitis viruses (A, B, C and D),
HEV is the only one with animal reservoirs.
Swine HEV was ﬁrst isolated and genetically
characterized from pigs in the USA in 1997
[89], even though HEV antibodies and RNA
were reportedly detected from pigs in the
Kathmandu Valley of Nepal but the identity of
the virus infecting the Nepalese pigs was not
determined in that study [21]. More recently, an
avian HEV was identiﬁed and characterized
from chickens with Hepatitis-Splenomegaly
(HS) syndrome in 2001[46] intheUSA aswell.
Besides swine and chickens, recently strains of
HEV have been genetically identiﬁed from deer,
mongooses, rabbits and rats [55, 99, 115, 141,
154]. Accumulatingevidenceindicatesthat hep-
atitis E is a zoonotic disease, and swine (and
likelyotheranimalspecies)arereservoirs.Swine
andhumanstrainsofHEVaregeneticallyclosely
related and, in some cases, indistinguishable
[78], and direct transmissions through the con-
sumption of contaminated food products such
asporkhavebeenreportedinJapan[149].Thus,
zoonotic transmission of hepatitis E raises an
importantpublichealthconcernoverfoodsafety
and zoonotic risk [95].
2. HEPATITIS E VIRUS BIOLOGY
AND CLASSIFICATION
2.1. Morphology, genome organization,
and protein expression
Hepatitis E virus belongs to the Hepeviridae
family. It is a spherical, non-enveloped virus
with an icosahedral symmetry [147]. Viral par-
ticles are approximately 32 to 34 nm in diame-
ter and composed of a capsid protein (ORF2)
assembled into a highly structured multimer
(60 copies). The buyoant density of native vir-
ion particles, isolated from infected patient
stools, is between 1.39 and 1.40 g/cm
3 in CsCl
and its sedimentation coefﬁcient is 183S [75].
T h eH E Vc a p s i dp a c k a g e sas i n g l ep o s i t i v e -
stranded RNA genome, which encodes 3 open
reading frames (ORF). The RNA genome of
HEVis capped at the 50 end, and polyadelylated
at the 30 end [48, 116] with approximately
7 . 2 k bi nl e n g t h .T h e5 0 and 30 extremities
of the viral genome are non-coding regions
probably involved in the regulation of viral
translation and replication [135]. The ORF1,
encompassing approximately two thirds of the
viral genome, encodes non-structural proteins.
Computer-based sequence analyses and predi-
cation, based upon the known motif of other
positive-strand RNA viral proteins, have
revealed several conserved putative functional
domains in ORF1, including methyltrasferase,
papain-like cystein protease, helicase, and
RNA dependent RNA polymerase (RdRp)
[68]. Due to the lack of efﬁcient in vitro cell
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regarding the translation and processing of the
ORF1 polyprotein. It has been shown that when
ORF1 is expressed in a baculovirus expression
system, synthesis of several small proteins that
correlate with the predictive motifs was
observed [124]. However, when the ORF1
was expressed in bacteria or mammalian cells,
no processing was observed [117]. Expression
of RdRp fused to an enhanced green ﬂuorescent
protein (EGFP) in hepatoma cell line HepG2
has shown an endoplasmic reticulum (ER)
localization suggesting that the HEV replication
complex may be associated with the ER [110].
An ER transmembrane domain was identiﬁed
in the RdRp region, and shown to interact with
the 30 end of HEV RNA [4, 110]. The second
ORF, ORF2, is located at the 30 end of the gen-
ome and encodes the capsid protein. ORF2 con-
tains an ER signal peptide and 3 putative
N-glycosylation sites [41]. When over-
expressed in the human hepatoma cell line
Huh7, the ORF2 protein is found to be
glycosylated (88 kDa) in the cytoplasm, after
a retrotranslocation from the ER [132]a n do n
the cell surface [150]. The ORF2 capsid protein
interacts with the 50 end of the viral RNAwhich
probably plays a role in the viral RNA encaps-
idation [131]. ORF2 is putatively translated
from a subgenomic RNA [108]. The reported
numbers and sizes of HEV subgenomic RNA
differed in infected livers and cell culture
[103, 108]. Recently, a bicistronic subgenomic
RNA, encoding both ORF2 and ORF3, was
identiﬁed using an in vitro HEV replicon sys-
tem [40]. The in vitro results were further veri-
ﬁed with an in vivo swine model demonstrating
that the third in-frame start codon (AUG) of
HEV is the authentic initiation site for ORF3,
and that ORF3 overlaps ORF2 but neither
O R F 2n o rO R F 3o v e r l a p sO R F 1[ 52]. The
ORF3 encodes for a small phosphoprotein of
123 amino-acids associated with cytoskeleton,
a n dm a yp l a yar o l ei nv i r u sr e p l i c a t i o na n d
virion morphogenesis [148]. ORF3 is necessary
for viral infection in rhesus macaques in vivo
but not in vitro [39]. In vitro, ORF2 and
ORF3 proteins interact with each other,
suggesting that ORF3 may play a role in viral
assembly of de novo particles [142].
Since there is no in vitro model with robust
viral replication, the virus life cycle remains
hypothetical. Currently, no speciﬁc interaction
with any cellular receptor has been described.
Supposedly, after adsorption and uncoating,
HEV RNA is probably ﬁrst translated into
non-structural proteins followed by the synthe-
sis of genomic and subgenomic RNA
[40, 108]. Replication complexes have been
observed, in vitro, at the ER membrane [110].
Subsequently the translation of ORF2 and
ORF3 proteins would occur, leading to the
assembly of viral particles and the release of
progeny virions. There is no evidence of a
direct cytopathic effect caused by HEV [136],
and it is more likely that the hepatocyte cytoly-
sis observed during infection is mediated by the
cellular immune response. Thus hepatitis E may
be an immune-mediated disease [128].
2.2. Taxonomy
Based upon its superﬁcial similarity in mor-
phology and genome organization to the cali-
civiruses, HEV was originally classiﬁed in the
Caliciviridae family [135]. The predicted puta-
tive functional motifs of HEV non-structural
proteins are also similar to those of Rubella
virus and alphaviruses of the Togaviridae fam-
ily as well as to the plant furoviruses [68]. The
HEV capping enzyme has properties very sim-
ilar to those of viruses within the ‘‘alphavirus-
like super group’’ [117]. A cap structure has
been identiﬁed at the 50 end of the HEV gen-
ome [60]. Although HEV shares several proper-
ties with these families, it has sufﬁcient
differences to be classiﬁed into a new Hepevi-
ridae family [30]. HEV genomes vary signiﬁ-
cantly and consist of at least four major
mammalian genotypes (1–4) and one avian
HEV [46, 101]( Fig. 1). Mammalian HEV and
avian HEV share only approximately 50–60%
nucleotide sequence identity, thus avian HEV
may constitute a separate new genus distinct
from the current genus Hepevirus. Genotype 1
and genotype 2 mammalian strains are
restricted in humans and mainly associated with
large waterborne epidemics in endemic regions
[78]; genotype 3 and 4 mammalian HEV strains
are found both in human and other mammalian
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and are mainly responsible for sporadic cases
of hepatitis E. Genotype 3 is found mainly in
Europe, the USA and Japan, and genotype 4
has been identiﬁed mainly in Asia (China,
Japan and India) [78] and occasionally in
Europe (Germany and one possible case
imported from Vietnam to Spain) [37, 144].
In addition to the prototype avian HEV strains
from the USA, several genetically-distinct
strains of avian HEV have been identiﬁed
recently from chickens in Australia and Europe
(Hungary and Spain), and there exist at least
three genotypes of avian HEV worldwide
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Figure 1. Phylogenetic tree representing 52 sequences of full length HEV genome retrieved from GenBank
(accession numbers are indicated). Alignment was performed using ClustalW in MEGA 3.1. and the tree
was built using the neighbor joining method with 1 000 bootstrap replicates. (A color version of this ﬁgure
is available at www.vetres.org.)
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of HEV was isolated from farm rabbits in
China. The rabbit HEV is most closely related
to HEV genotype 3 with approximately 82%
of nucleotide sequence homology, suggesting
that rabbit HEV may be a variant of genotype
3[ 154]( Fig. 1). Currently there is little informa-
tion regarding the host range and zoonotic
potential of this rabbit HEV. Since the rabbit
HEVisavariantofgenotype3,itispossiblethat
the rabbit HEV may also have the ability to
infect across species. More recently, a new hep-
atitis E-like virus was identiﬁed in the feces of
wild rats in Germany. Partial sequence analyses
showed that the rat HEV only shares approxi-
mately 59.9% and 49.9% sequence identities,
respectively, with known human and avian
HEV, suggesting that rat HEV may represent
an additional new HEV genotype within the
hepevirus genus [55]. The complete genomic
sequence of the rat HEV is needed for a deﬁni-
tive classiﬁcation. It remains to be determined
whether or not rat HEV can infect humans.
3. PATHOGENESIS IN HUMANS
Hepatitis E is transmitted by the fecal-oral
route, usually via the consumption of contami-
nated water or food. In contrast to hepatitis A
virus and other enteric viruses, human-to-
human transmission of HEV is rare [1]. From
a clinical point of view, hepatitis E is similar
to hepatitis A, with acute self-limiting and
symptomatic disease that varies in severity from
subclinical to fulminant [29]. Incubation time
r a n g e sf r o m2w e e k st o2m o n t h sw i t ha na v e r -
age of 40 days, viremia is transient and occurs
mainly during the prodromic phase, and disap-
pears at the onset of clinical symptoms. Fecal
excretion of the virus begins a few days (5 days
on average) prior to jaundice, and regresses at
the onset of jaundice within 2 to 3 weeks [2].
Most autochtonous cases of hepatitis E are
reported in middle-aged and elderly men
[109]. Fulminant hepatitis is observed in
1–4% of the cases which is higher than hepatitis
A[ 69]. The mortality rate reaches up to 20%
in pregnant woman in some endemic areas
(northern and central India, Pakistan)
[53, 67]. In other countries such as Egypt or
southern India, pregnant women are not signif-
icantly at higher risk to develop fulminant hepa-
tic failure (FHF) [100, 129]. More recently, a
20-year study of the association of HEV-associ-
ated acute liver failure with pregnancy revealed
that the mortality of pregnant patients is similar
to that of nonpregnant women [9]. Pregnancy is
a poor prognostic factor for a patient with acute
liver failure associated or not associated with
HEV infection [9]. Thus, various factors such
as HEV strains (genotype or subtypes), viral
load, or other co-infections might play a role
in pathogenesis [112]. It appears that, compared
to genotypes 1 and 2, the genotype 3 and
4 strains are less pathogenic in humans. There-
fore, the differences of HEV genotypes in dif-
ferent geographical regions might explain the
severity of infection during pregnancy. How-
ever, in Egypt and southern India where geno-
type 1 HEV is prevalent, low mortality rates
are observed during pregnancy, thus suggesting
t h a to t h e rf a c t o r sm a yb ei n v o l v e di nt h e
observed high mortality rate during pregnancy
in some regions [100]. To our knowledge, no
cases of fulminant hepatitis E associated to
genotype 3 infection during pregnancy have
been reported [5].
More recently, other clinical forms of HEV
diseases have been observed in patients under
immunosuppressive conditions, such as trans-
plant recipients [63], or patients suffering from
leukemia [71].Someofthesepatientsdeveloped
chronic HEV infection progressing to cirrhosis
[62]. This clearly suggests that the atypical clin-
ical and virological outcome for HEV infection
in these cases could be related to immunosup-
pressive treatments, which might have resulted
in suboptimal anti-HEV-speciﬁc immune
responses and subsequent viral persistence.
Such a hypothesis has been evocated by Kamar
et al. [63] who found signiﬁcantly reduced
CD2-, CD3-, and CD4-lymphocyte counts in
patients with chronic disease, andin populations
at risk of developing FHF. Another population
that might be at risk of chronic HEV infection
are HIV patients with an advanced stage of
immunodeﬁciency. However, so far there has
been no increased prevalence of HEV infection
observed in that population [79, 113]. Only a
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reported in HIV patients [24], including a preg-
nant woman who recovered completely [139].
In non-endemic regions, the number of hep-
atitis E cases in humans seems to be on the rise
largely due to an increasing interest in this dis-
ease. Recent efforts have been done to evaluate
the reliability of HEV diagnostic tools [10, 74].
One retrospective study has reported that the
incidence of hepatitis E in France was stable
over a period of 5 years, suggesting that hepa-
titis E is generally under-diagnosed [80]. Clini-
cians need better awareness of this disease in
order to accurately determine the incidence of
HEV infection.
4. ANIMAL RESERVOIRS
AND PREVALENCE
Domestic pigs and wild boars are the main
animal reservoir for the genotypes 3 and 4
strains of HEV worldwide [95]. Besides pigs,
anti-HEV antibodies have also been detected
in many other animal species including deer,
rats, dogs, cats, mongooses, cows, sheep, goats,
avian species, rabbits and horses [55, 99, 115,
121, 141, 152, 154] suggesting that these ani-
mal species are exposed to HEVor to a closely
related agent. While strains of HEV genotype 3
and/or 4 have been genetically identiﬁed in the
wild boar, deer, mongoose and rabbit [154], the
source of seropositivity in other animals, with
the exception of chickens [46]a n dr a t s[ 55]
remains unknown [95].
4.1. Prevalence of HEV in pigs
Several descriptive studies on HEV preva-
lence have been carried out in swine herds in
different countries. The nature of the collected
information is very diverse among studies:
detection of different classes of anti-HEV anti-
bodies IgG and sometimes IgM and/or IgA
[36, 72, 97, 134], detection of viral RNA by
RT-PCR in serum samples [134], feces from
individual pigs or slurry, [49, 119], or commer-
cial liver from grocery stores [33, 57, 149]. All
serological studies converged on a very wide
distribution of HEV in swine herds. If we
consider that a herd is positive when at least
one individual is identiﬁed as being seroposi-
tive, the following was found: 100% (15/15)
were positive in the USA [89], 90% (20/22)
in New Zealand [38], 46% (23/50) in Laos
[14], 100% (10/10) in Mexico [25], and 98%
(40/41) in Spain [125]. A retrospective study
performed in Spain, including 208 herds fol-
lowed since 1985, shows that endemic HEV
infection in pigs is not a recent phenomenon
(204/208 = 98%) [20]. At the individual level,
in pigs of 6 months of age, the average sero-
prevalence varied greatly from study to study:
56% of HEV-positive pigs in Japan [134],
23% in Argentina [97], 81% in Brazil [42],
and 51% in Laos [14]. The observed high var-
iability of seroprevalence rate results from
important differences within each herd (4 to
58% for the Argentine study [97], 15 to 100%
for the Brazilian study [42]). Strong ﬂuctuations
in seroprevalence rate are also observed accord-
ing to the animal’s age, with pigs older than
4 months generally being higher [134]. This
observation is consistent with a natural HEV
infection of pigs between 10 and 12 weeks of
age. In a prospective study of a swine herd in
the USA, the majority of swine became infected
at the age of 2 to 4 months [89], consistent with
the high seroprevalence rate in pigs older than
4 months old. The IgG anti-HEV seropreva-
lence rate in sows is higher, ranging from 60
to 73% [38, 125].
The detection of HEV RNA in sera shows
a very strong inﬂuence of the age of animals
as shown in a Japanese study [134]. The highest
number of viremic animals is observed at
3 months of age (32/310 positive). In this study,
none of the 136 animals tested at 6 months of
age were positive. In the Netherlands, a survey
was performed in 97 herds with 20 weeks old
pigs: 53 herds (55%) contained at least one ani-
mal excreting the virus in feces [119]. Faecal
excretion of HEV seems to heavily depend on
the age of the animals, peaking at 18 weeks
of age (86% of the pigs with fecal virus shed-
ding), and decreasing afterwards to 41% at
the age of slaughter, as shown in a study per-
formed in Canada [72]. In accordance with
these data, the results obtained in Spain [36]
show the highest number of positive pigs
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weeks of age, and the results from the United
Kingdom [88] show the highest number of ani-
mals with faecal excretion at 10–12 weeks of
age (22%), decreasing to 4% for pigs older than
22 weeks of age. In the various studies carried
out in Europe, the HEV strains identiﬁed that
all belong to genotype 3 [88, 125].
Under natural conditions of infection, the
dynamics of HEV infection is similar to what
is described for most viral infections in pigs:
acquisition of passive immunity through colos-
trum absorption (60% of the piglets), progres-
sive decline of these passive antibodies at
8–10 weeks of age, then seroconversion
between 14 and 17 weeks of age (Fig. 2) corre-
sponding to the peak of viremia observed at
15 weeks of age (40% of animals) [26]. In a
Spanish study, the percentage of viremic pigs
increased from 9 weeks to 15 weeks of age
and gradually decreased towards slaughter age
[26].TheIgManti-HEVincreasedfrom9weeks
of age, and approximately 100% of the pigs
studied (n = 16) were IgG anti-HEV-positive
at 22 weeks of age (Fig. 2). This dynamics
observed in a Spanish herd is also in accor-
dance with what was observed in Japan where
the peak of faecal virus excretion was between
1 and 3 months of age (75 to 100% of the ani-
mals) then decreased to 7% of the animals at
5–6 months of age [98]( Fig. 2). The seroprev-
alence observed at the end of fattening reveals
an effective transmission of the virus between
the animals from the same fence. This was con-
ﬁrmed by the experimental estimation of the
basic reproduction ratio (R0)o fH E Vw h i c hi s
estimated to 8.8 [17], revealing the theoretical
possibility for 1 infected pig to infect more than
8 animals of a naive population during its infec-
tious period [17].
4.2. Prevalence of HEV in wild boars and deer
A few studies report the presence of HEV in
wild boars and deer in Europe and Japan [27,
58, 61, 81, 86, 96, 115, 120, 122, 127, 141].
The seroprevalence rates observed in wild boars
are variable from 9 to 71%, and in deer from
2 to 35% (Tab. I). The prevalence of HEV
RNA ranges from 3 to 25% in wild boars
IgG anti-HEV
IgM anti-HEV
Virus in feces
0246 8 1 0 1 2 1 4 1 6 1 8 2 0 2 2 2 4
Age in weeks
Maternal anti-HEV
HEV Infection
Figure 2. Approximation of the natural time course of HEVinfection in pigs. Representation of the kinetics
of seroconversion: maternal anti-HEV antibodies (dark blue), IgM anti-HEV (green), IgG anti-HEV (light
blue) and fecal excretion of HEV (red) in pigs infected naturally. Adapted from the results presented in
Section 4.1: prevalence of HEV in pigs). (A color version of this ﬁgure is available at www.vetres.org.)
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reported that approximately 34% of deer livers
were positive for HEV RNA (11/32) (Tab. I).
In these studies, reporting on divergent prev-
alence, sample sizes were generally small and
of various origins such as the liver, sera, bile,
and feces (Tab. I). There were limited data on
the age of the animals tested, which makes it
difﬁcult to evaluate the real infection level of
these animal species. The HEV strains ampli-
ﬁed from these animal species were of genotype
3 or 4 and were genetically very closely related
to human and swine strains described in the
same geographic regions [115, 133], and thus
suggesting possible interspecies transmission.
The presence of genotype 3 HEV in the
Japanese mongoose (8.3%, 7/84) has been
reported in southern Japan (Okinawa) [77, 99],
although no human case associated with this
reservoir has been reported so far.
4.3. Prevalence of HEV in rodents and other
animal species
Rodents are present in both urban and rural
areas and thus, may play an important role in
HEV transmission. Rats from both urban and
rural areas have been detected to be seropositive
for IgG anti-HEV. It has been shown that about
77% of the rats from Maryland, 90% from
Hawaii and 44% from Louisiana were positive
for IgG anti-HEV [59]. The IgG anti-HEV
prevalence rate increases in parallel with the
estimated age of the rats. All three species of
wild rats (Rattus norvegicus, Rattus rattus and
Rattus exulans)t e s t e di nt h es t u d yw e r es e r o -
positive. In another study, 26 different species
of rodents caught in the USA were tested for
IgG anti-HEV prevalence, and the highest preva-
lenceratewasfoundinthegenusRattus(59.7%).
Rodents caught in an urban area had a higher
IgG anti-HEV prevalence rate than rodents
caught from rural areas [32]. In Japan, it is
reported that approximately 32% of Norway rats
(R. norvegicus) and 13% of black rats (R. rattus)
were seropositive for IgG anti-HEV [47]. The
seroprevalence of HEV antibodies in different
rodent populations varied in different geographic
regions[94].Theseresultsindicatedthatthereisa
widespread infection of rats by HEV in different
countries. The recent genetic identiﬁcation of a
strainofHEVfromratsinGermany[55]conﬁrms
these serological ﬁndings. It appears that the rat
HEV is genetically distinct from the known
strains of mammalian HEV. It remains unknown
whetherornottheratHEVhastheabilitytocross
the species barrier and infect humans.
Immunoglobulin G anti-HEV was also
reportedly detected in dogs in Vietnam and
India, in cows from India, Somali, Tajikistan,
Table I. HEV in wild boars and deer.
Country Animal species Serology HEV RNA genotype 3 Type of sample Reference
Japan Yezo deer 34.8% (181/520) nd Serum [141]
Japan Wild boar 9% (n = 35) nd Serum [127]
Wild deer 2% (n = 117) nd Serum
Japan Boar [96]
Wild-caught 25% (100/392) nd Serum
Bred 71% (10/14) 3% Serum
Hungary Wild boar nd 12.2% (9/74) Liver [115]
Roe deer nd 34.4% (11/32) Liver
Germany Wild boar nd 5.3% Serum [61]
Germany Wild boar nd 15% Liver [122]
Italy Wild boar nd 25% (22/88) Bile [81]
Spain Wild boar 42.7% 19.6% Serum [27]
The Netherlands Wild boar nd 4% Feces [120]
France Wild boar nd 2.5% (7/285) Liver [58]
nd: Not determined.
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goats from Turkmenistan [7, 140]. However,
the source of seropositivity in these animal spe-
cies could not be deﬁnitively identiﬁed thus far.
Nevertheless, the existence of a population of
animal species positive for IgG anti-HEV
suggests that pigs may not be the only animal
reservoir for HEV.
5. ANIMAL MODELS AND TARGET
ORGANS
5.1. Animal models and cross-species infection
Animalmodelshavebeendevelopedtostudy
HEV replication and pathogenesis. One animal
model was developed in non-human primates:
cynomolgus macaque (Macaca fascicularis)
[91] or less frequently chimpanzee [87]. The
non-human primates were used mainly to study
genotypes 1 and 2 HEV strains. A second ani-
mal model was developed in pigs [90]i nw h i c h
genotypes 3 and 4 replicate efﬁciently. Both
non-human primate and pig models were used
to demonstrate cross-species infections or extra-
hepatic sites of HEV replication [145]. More
recently, a third animal model was developed
in speciﬁc-pathogen-free chickens [12]t os t u d y
the avian strains of HEVand the HS syndrome
associated with avian HEV infection [13].
The ﬁrst two models of HEVinfection (non-
human primates and swine) represent limited
clinical interest for viral pathogenesis studies,
the animals remain asymptomatic, only viremia
with virus shedding in feces and seroconversion
were observed [3, 45]. Very moderate increases
in hepatic enzyme activities and minor
hepatic pathological lesions were occasionally
observed [3].
Initially, the macaque model was developed
to study genotype 1 and 2 HEV strains isolated
from humans, although non-human primates
are susceptible to all 4 genotypes of HEV
[95]. This model was used to demonstrate that
cross-species infections occur, since inoculation
of rhesus macaques (Macaca mulatta) with
swine HEV genotype 3 or 4 strains led to
productive infections [8, 91]. Slight elevation
of serum liver enzymes, fecal excretion and
seroconversion to IgG anti-HEV were observed
[8]. Comparison of pathological lesion proﬁles
after infection with genotype 3 human or swine
HEV did not reveal major differences, suggest-
ing that genotype 3 or 4 HEV strains have no
speciﬁc host restriction between swine and pri-
mates [91]. However, an attempt to experimen-
tally infect rhesus macaques with the avian
HEV strain failed, suggesting that the avian
HEV strain represents a limited risk for human
infection [51]. Swine are naturally infected by
genotype 3 or 4 HEV but are not susceptible
to infections by genotype 1 of the Pakistani
strain (Sar-55) of HEV nor to infection with
the Mexican strain of genotype 2 [90]. The
molecular mechanism underlying this host
restriction remains unknown. Genotype 3 and
4 HEV strains isolated from humans are infec-
tious when inoculated into pigs [35, 91]. The
comparison of pathological lesions between
the genotype 3 swine and human HEV strains
did not reveal a major difference [45]. The
experimental infection of pregnant gilts with
genotype 3 swine HEV did not lead to any
fulminant hepatitis, abortion or vertical trans-
mission [64]. It is hypothesized that the geno-
type 3 swine HEV or human HEV is less
virulent than genotype 1 or 2 HEV [109].
It has been demonstrated that chickens can
serve as a good model for the study of avian
HEV replication and pathogenesis [12]. Unlike
the swine and non-human primate models in
which reproduction of HEV infection by the
oral route of inoculation has been difﬁcult,
chickens can be readily infected with avian
HEV via the natural oral route [12]. Evidence
of vertical transmission has been demonstrated
in the chicken model infected with avian
HEV. Avian HEV detected in chicken egg white
was found to be infectious, although no virus
was detected in samples collected from the
hatched chicks, suggesting that avian HEV
could not complete the vertical transmission
cycle [43]. The host range of avian HEV
appears to be limited. Although the avian
HEV can infect turkeys [130], attempts to infect
pigs and rhesus monkeys with avian HEV were
unsuccessful
1 [51]. In addition, a genotype 3
1 Meng et al., unpublished data.
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5.2. Target organs
The main target organ of HEV replication in
the pig is the liver but HEV infection is totally
unapparent in pigs [73]. Mild hepatic lesions
characteristic of hepatitis have been described
in experimentally-infected pigs [45], and in
naturally-infected pigs in the USA [89]a n di n
Spain in the context of post-weaning multisys-
temic wasting syndrome [82].
Studies on HEV dissemination in pigs
infected experimentally by intravenous inocula-
tion (IV) have identiﬁed extrahepatic sites of
HEVreplication. As expected, evidence of viral
replication was found in the liver but also in the
colon, lymph nodes (mesenteric and hepatic)
and spleen for up to 20–27 days post-inocula-
tion [145]. The virus RNA was also detected
in the stomach, small intestine, spleen, kidney,
salivary glands, tonsils or lungs (14 days post-
inoculation). Viral RNA, but no viral replica-
tion, was detected in the muscles at 14 days
post-infection at which time the pigs also had
viremia [145]. In a recent study, comparing
the course of HEV infection in pigs via
contact-infection or IVinoculation, the presence
of HEV RNA was conﬁrmed in Longissimus,
Biceps, Femoris and Iliopsoas muscles at 27
days post-inoculation in IV-inoculated pigs
and 31 days in contact-infected pigs [18]. These
HEV RNA-positive organs may result from
viremia, rather than from active virus replica-
tion, but they may still represent a risk of
HEV contamination of pork products. It has
been shown that the results obtained after con-
tact-infection or IV-inoculation of pigs were dif-
ferent, suggesting that the route of HEV
infection may inﬂuence viral dissemination.
HEV was found in urine after contact infection
(3/5) but not in IV-inoculated pigs (0/5) [18].
The presence of HEV in urine, in addition to
feces, may contribute to the high transmissibil-
ity of HEV between animals. The IV route is
commonly utilized in experimental infection
since it is more efﬁcient than fecal-oral or
contact-exposure routes but may not reﬂect nat-
ural HEV infection [65]. By using the chicken
model, Billam et al. reported on the identiﬁca-
tion of extrahepatic sites of HEV replication
in animals after experimental infection via the
natural oral route of HEV inoculation [13]. In
addition to the liver, replicative HEV RNA
was also detected in gastrointestinal tissues,
including the colorectal, cecal, jejunal, ileal,
duodenal, and cecal tonsil tissues [13].
The omnipresence of HEV infection in pigs
and the detection of HEVreplication in the liver
raised the concern for the presence of HEV in
slaughtered pigs and in livers sold in grocery
stores. Several studies reported the detection
of HEV RNA in commercial pig livers: 1.9%
(7/363) in Japan (genotypes 3 and 4) [149];
6.5% (4/62) in the Netherlands (genotype 3)
[15]; 10.8% in Korea (genotypes 3), samples
collected between 1995 and 2004 [57], 0.83%
(2/240) in India (genotype 4) [70]a n di n1 1 %
in the USA [33] (genotype 3). In the last study,
the presence of infectious virus in commercial
livers was conﬁrmed by inoculation of HEV
RNA-positive liver homogenate into pigs [33],
raising the possibility of human infection
through consumption of contaminated pork
products. In order to study if heating (cooking)
would inactivate HEV, small pieces of HEV
RNA-positive livers were cooked at different
temperatures and the residual infectious virus
was measured in a swine bioassay [34]. The
results showed that deep fried (5 min at
191 C) or boiling (5 min) can effectively inac-
tivate HEV, although a treatment of 1 h at
56 C did not inactivate HEV [34]. These
results underline that contaminated food prod-
ucts, if consumed raw or undercooked, could
potentially transmit the virus to humans. There-
fore, some food preparations, such as mid-dry
liver sausage, should be consumed after cook-
ing to minimize potential HEV infection.
6. ZOONOTIC TRANSMISSION
Two cases of conﬁrmed zoonotic transmis-
sion of HEV through the consumption of con-
taminated animal food products have been
reported in Japan (Tab. II, upper) [76, 138].
2 Sun and Meng, unpublished data.
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or 60 days after consumption of Sika deer
(sushi) or wild boar (grilled) meat. In both
cases, HEV RNA was successfully ampliﬁed
in the patients as well as in the leftover frozen
animal meat. The HEV viral sequences recov-
ered from the patients and from the leftover fro-
zen meats are either identical or near identical
with 99.95% identity, conﬁrming the zoonotic
nature of transmission through the consumption
of animal food products. In one of these cases,
the level of HEV contamination of the meat
was estimated by quantitative RT-PCR to be
approximately 10
5 genome equivalents (GE)
per gram of meat. There was no indication on
the quantity of meat ingested by the patient
nor the type of meat (liver or muscle) involved
[138].
In four other studies in Japan, HEVinfection
via the consumption of contaminated food was
supported by several pieces of evidence. In all
cases, hepatitis E were observed 14 to 60 days
after consumption of raw or under cooked pork
products [83, 85, 137, 149]: wild boar barbe-
cue, raw wild boar liver, grilled or uncooked
pork liver (Tab. II, bottom). IgM and/or IgG
antibodies and/or HEV RNA were detected in
patients who shared the same meal with the
index-case(s) [83, 85, 137, 149]. Very recently
in France, a case-control study showed that
Table II. Cases of zoonotic HEV transmission through consumption of contaminated foodstuffs.
No. of cases/
incubation time
Animal species Cooking/
recipe
Genotype Elements in favor of
a zoonotic transmission
Reference
country
Conﬁrmed
4
40 days
Sika deer Slice of raw
meat (sushi)
3 100% of sequence
homology between
patient and meat
(frozen). 10
5 GE/g meat
[138] Japan
1
60 days
Wild boar Grilled 3 Almost 100% (99.95)
of sequence homology
between patient
and meat (frozen).
[76] Japan
Putative
2
30 to 60 days
Wild boar Raw liver 4 Share and consumption
of the same meal.
2 patients IgM and IgG positive
and one of the two patients
was HEV RNA positive.
[85] Japan
5
39 days
Wild boar Grilled
(Barbecue)
3 On 12 persons attending
the same meal:
8/12 IgM +, 11/12 IgG +
and 2/12 RNA +
[137] Japan
1
59 days
Wild boar Grilled marinated
meat (Barbecue)
3 The patient was IgM,
IgG and
HEV RNA positive
and 1 person with
high anti-HEV IgM had
shared the same meal.
[83] Japan
10
14 to 60 days
Pork Grilled liver,
undercooked, rare
3, 4 9/10 patient had consumed
raw or undercooked
pig liver earlier.
[149] Japan
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linked with autochtonous hepatitis E human
cases
3. Thus, among the possible contamination
pathways of HEV, contaminated food must be
seriously considered. A recent German study
also supports a foodborne origin of HEV infec-
tion [144]. A case-control study was performed
and the risk factors found, independently asso-
ciated with autochthonous HEV infection, were
offal consumption (41% versus 19%) and wild-
boar meat consumption (20% versus 7%). The
meat products implicated should be investigated
for the presence of HEV. These data would con-
tribute to deﬁne preventive measures [144].
Another possible way of HEV exposure is
through direct contact with animals. Higher
anti-HEVantibody prevalences within individu-
als in close contact with pigs have been
reported: slaughterhouse staff, veterinarians
and pig breeders. A survey in a cohort of 295
veterinarians from 8 American states showed
an antibody prevalence of 27% in swine veter-
inarians versus 16% in the general population
[93]. Both swine veterinarians and normal
blood donors, from traditionally-major swine-
producing states are more likely to be seropos-
itive than subjects from traditionally non-major
swine-producing states [93]. A limited number
of pig handlers in two endemic countries (China
and Thailand) were also tested for IgG anti-
HEV prevalence, and most of them were found
to be seropositive for HEV [92]. In Sweden,
a study also showed a high prevalence of
HEV antibodies within the pig breeders’ popu-
lation (13%) [102]. To support these data, a
Bayesian approach was used in the Netherlands
to estimate a seroprevalence rate of approxi-
mately 11% for swine veterinarians, 6% for
non-swine veterinarians and 2% for the general
population [16]. In Moldova, it has been
reported that approximately 51% of swine farm-
ers were IgG anti-HEV positive whereas only
25% of control subjects with no occupational
exposure to swine were seropositive. Swine
farmers with a history of cleaning barns or
assisting pig birth were 2.46 times more likely
to be seropositive than controls [28]. In North
Carolina, Withers et al. reported that swine
workers had a 4.5-fold higher anti-HEV preva-
lence (10.9%) than the controls (2.4%) [146].
Recently, an acute hepatitis E was reported
in a person who had been given a pet pig
2 months before the onset of symptoms. HEV
sequences closely related to the sequence recov-
ered from the patient were identiﬁed from the
animal, and shown to belong to the genotype
3 HEV strain with 94% nucleotide sequence
identity [111]. Thus, contact with animals and
especially swine increase the risk of HEV
exposure.
The possible source of HEV infection in
these cases could be feces or manure, since
large amounts of virus can be excreted in feces
[66]. One study has investigated the presence of
HEV in manure storage facilities (earthen
lagoons or concrete pits) [66]. HEV-contami-
nated efﬂuents were detected in seven of the
28 farms investigated with up to 10
3 GE of
HEV genomic RNA per 60 mL of pit samples.
The presence of infectious virus was conﬁrmed
by a swine bioassay [66]. None of the water
samples tested in the farm vicinity was positive
[66]. Manure storage and spreading may vary
from country to country, and thus further inves-
tigations should be done to evaluate this possi-
ble contamination pathway. Furthermore, a
recent study has investigated zoonotic, food-
borne, or water-borne origin of genotype 3
HEV infections in people in The Netherlands.
Interestingly, 17% of surface water samples
were found positive [120]. The possible HEV
contamination of the environment is thus of
concern and must be further studied.
To evaluate the risk associated with zoonotic
HEV transmission, a piece of very important
data such as a dose-response model for HEV,
is still missing. Since there is no efﬁcient
in vitro cell culture model to propagate HEV,
little is known on HEV infectivity. The number
of infectious particles in correlation with the
number of genome equivalent (GE, estimated
by semi-quantitative RT-PCR) has been
estimated using the pig model [65]. A titration
of a suspension containing 10
6 (GE) was
3 Colson P., Gerolami R., Hepatitis E – France:
(Marseille) pig liver sausage, ProMED-mail PRO/
AH/EDR 2009; 17 Sep: 20090917.3267 [on line]
http://www.promedmail.org[consulted22Feb2010].
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10
4.5 50% pig infectious dose (PID50)[ 65].
Thus, one PID50 corresponds to approximately
10
1.5 GE, but IV inoculation is not a natural
route of HEV transmission, except in cases of
blood transfusion [23, 84]. Another study has
s h o w nt h a tp i g so r a l l yi n f e c t e dw i t h1 0
5.3 GE
had seroconverted, or excreted virus in 25%
of the cases (4/16) [19]. Thus, the data suggest
that infection by HEV genotype 3 requires high
copy numbers of GE in animals. This observa-
tion might be different for genotypes 1 and 2 in
humans, although this can serve as an indicator.
7. DIAGNOSIS AND PREVENTION
Viral hepatitis E is similar to the other types
of acute viral hepatitis. Usually HEV markers
are tested after the patients are found to be neg-
ative for the following tests: IgM antibodies to
hepatitis A virus; AgHBs, anti-HBc IgM, and
DNA to hepatitis B; antibodies and RNA to
hepatitis C virus; IgM antibodies for Cytomeg-
alovirus and Epstein Barr Virus; anti-nuclear,
anti smooth muscle and anti-LKM-1 antibodies
[114]. Acute hepatitis E diagnosis is based on a
ten times higher ALT elevation than the normal
value and the presence of increasing anti-HEV
IgG titers and/or the presence of anti-HEV
IgM and/or HEV RNA in the serum and/or
stool samples [114]. Several diagnostic kits
for HEV serology in humans are available
and have been validated. Detection of anti-
HEV IgM with the recent commercial kits
seems to be speciﬁc and reliable [74]. Many
RT-PCR and quantitative RT-PCR have been
developed for HEV RNA ampliﬁcation in dif-
ferent laboratories, but no commercial kit is
available [56, 123, 153].
Since HEV infection is asymptomatic in
swine, HEV diagnosis is not performed rou-
tinely in pigs. HEV serology or detection of
HEV RNA is performed only in research labo-
ratories that have developed assays adapted to
swine [14, 20, 26, 31, 54, 105]. HEV genotype
3 and 4 strains present in animals are geneti-
cally very similar to human HEV genotypes
3 and 4, thus they can not be distinguished
by speciﬁc RT-PCR ampliﬁcation [25, 44,
56, 143]. HEV detection in swine herds is
important to measure the level of contamination
of this large animal reservoir especially in coun-
tries with industrial swine farming. Sensitive
and speciﬁc RT-PCR assays have been devel-
oped in independent laboratories to detect
all 4 mammalian genotypes of HEV
[25, 49, 143]. More recently, a nested broad-
spectrum RT-PCR capable of detecting different
HEV types, including the four mammal geno-
types, chicken strains and the new HEV type
of rats was reported, and this assay was success-
fully used to amplify the rat HEV [55]. Since
only one serotype of HEV has been described,
detection of anti-HEV antibodies in swine can
be performed using commercial kits for humans
adapted to swine or in-house tests with geno-
type 1 or 3 HEV antigens in ELISA [31, 54,
105, 118]. Although various HEV seropreva-
lence rates in swine have been reported, the
tests used have not been validated due to
the absence of appropriate ‘‘gold standards’’
[14, 20, 26, 54, 106, 151].
Currently, avian HEV diagnosis is primarily
based on detection of avian HEV RNA by
RT-PCR or detection of avian HEV antibodies
by ELISA [50, 104]. However, the sensitivity
and speciﬁcity of these assays are not known.
Avian HEV capsid protein has been expressed
and used in an ELISA to detect avian HEV
antibodies in chickens [50, 104]. Avian HEV-
speciﬁc RT-PCR assays have also been success-
fully developed for the detection of avian HEV
infections in chickens [50, 104]. However, the
speciﬁcity of the RT-PCR assays in detecting
avian HEV strains in chickens from different
geographic regions is not known, since avian
HEVstrainsidentiﬁedfromchickensindifferent
geographic regions are genetically heterogenic.
Efforts on HEV prevention concern mostly
sanitation in developing countries, to limit con-
tamination of drinking water by infected mate-
rials. Particular information and surveillance
must be taken with populations at higher risk
of fulminant hepatitis such as pregnant women
and people with underlying liver conditions. In
industrialized countries, where zoonotic trans-
missions may be the main route of hepatitis E
infection, consumers of raw or undercooked
meat should be advised on the potential risk.
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transplant recipients and individuals with under-
lying liver conditions should be informed on
the possible risk of consuming raw pork, deer
or wild boar meat or having contact with
infected pigs. In the same line, pig handlers
and veterinarians who are exposed to HEV,
must take hygienic measures after handling
the animals. In swine, since HEV seems very
contagious between animals [17], further inves-
tigation must be performed to determine if
farming procedures would limit HEV dissemi-
nation. Commercial importation of swine is a
very common practice and a better surveillance
strategy should be developed. Very recently,
a genotype 4 was isolated in swine for the ﬁrst
time in Europe
4. Investigations on the appear-
ance of this genotype are needed. Since swine
represent a large reservoir of HEV in non-ende-
mic region, pigs are probably one of the sources
of infection for the sporadic cases of acute hep-
atitis E. Surveillance of swine, with wild boar
and deer reservoirs should be performed until
all the routes of human exposure to HEV are
identiﬁed.
HEVinfection can be prevented as well with
an efﬁcient immunization program [109]. Since
HEVhasonlyoneserotypeandnaturalinfection
leads to protective antibodies [109], HEV is a
good candidate for the development of an effec-
tive vaccine. A large vaccination campaign in
developing countries would reduce large water-
borne epidemics with thousands of people con-
cerned. Travellers to endemic regions could
also beneﬁt from a vaccine. In industrialized
countries, populations at risks such as transplant
recipients or people with underlying liver condi-
tions could be a target for vaccination as well.
The safety and efﬁcacy of an HEVrecombinant
protein vaccine was evaluated in a phase 2, ran-
domized, double-blind, placebo-controlled trial
[126]. This vaccine, based on the HEV capsid
protein, showed a good efﬁcacy (88.5% after
one doseand95.5%afterthreedoses)inthe pre-
vention of hepatitis E in patients [126]. How-
ever, with the recent identiﬁcations of
genetically distinct strains of HEVin swine, rats
and rabbits, it will be important to determine if
the experimental vaccines are effective against
these emerging and potentially zoonotic strains
of HEV.
8. CONCLUSION
Although the zoonotic risk of HEV is now
well established, only few cases (two, world-
wide) of transmission from animals (deer and
wild boar) to humans have been deﬁnitively
conﬁrmed. Other possible transmission path-
ways remain to be identiﬁed especially in
non-endemic countries where the numbers of
autochthonous cases are on a steady rise. An
important issue of this disease is the evaluation
of risk factors associated with HEV infection
and the clinical consequences related to viral
exposure. Quantitative risk assessments should
be performed to identify and prioritize possible
routes of transmission. This approach will con-
tribute to precisely deﬁne the strategy of HEV
surveillance. The impact of HEV animal reser-
voirs on human infections must be studied to
evaluate whether, and how, zoonotic transmis-
sions should be controlled. Particular attention
on HEV genetic variability and recombination
in animals must be paid to prevent the potential
emergence of more pathogenic strains of HEV.
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